First narrow-spectrum antibiotic successfully eliminates Fusobacterium nucleatum, a gum disease pathogen

In a study published in the Journal of Oral Microbiology, ADA Forsyth scientists found that FP 100 (Hygromycin A), a first-in-class, small molecule, narrow-spectrum antibiotic, successfully eradicates Fusobacterium nucleatum without harming the oral or gut microbiomes.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup